Market Outlook

By 2035, the U.S. Edge Computing in Connected Medical Devices Market is projected to reach approximately USD 22.55 billion, expanding at a CAGR of 24.7% during the forecast period 2026–2035. The market is estimated at USD 2.48 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The historical market expanded from approximately USD 1.10 billion in 2021 to USD 2.02 billion in 2024, supported by accelerating adoption of connected patient monitoring, artificial intelligence-enabled imaging, continuous glucose monitoring, digitally connected therapeutic devices, hospital-at-home infrastructure, and distributed clinical computing. The market is projected to reach approximately USD 3.09 billion in 2026, USD 4.81 billion in 2028, USD 7.48 billion in 2030, USD 11.63 billion in 2032, and USD 22.55 billion by 2035.

The market definition covers edge-computing hardware, embedded processing systems, AI accelerators, medical-device gateways, edge software, device orchestration, cybersecurity layers, middleware, analytics, integration services, and hybrid edge-cloud infrastructure that are embedded within connected medical devices or directly enable their clinical operation. General-purpose hospital IT infrastructure without a direct connected-device workload is excluded.

The commercial rationale for edge computing in connected medical devices is increasingly clinical rather than purely technological. Medical devices now generate continuous streams of physiologic signals, imaging data, waveforms, alarms, video, device-status information, therapeutic measurements, and diagnostic outputs. Sending every data point to a centralized cloud environment before acting on it creates latency, bandwidth, resilience, privacy, and workflow constraints. Edge computing allows selected processing to occur within the medical device, beside the device, within a clinical gateway, or at an on-premises hospital edge node before relevant information is transferred to enterprise or cloud environments.

This architecture is particularly valuable when decisions must occur in milliseconds or seconds. Continuous bedside monitoring, autonomous imaging functions, robotic surgery, infusion safety, anesthesia management, critical-care surveillance, arrhythmia detection, glucose-management systems, endoscopic visualization, emergency transport, and AI-assisted diagnostic imaging increasingly require local processing even when cloud connectivity is degraded or temporarily unavailable.

The scale of the U.S. healthcare delivery environment creates a significant installed base for such technologies. The United States operates approximately 6,100 hospitals with more than 907,000 staffed hospital beds and over 35 million annual admissions. At the same time, Medicare remote patient monitoring payments exceeded USD 500 million in 2024, reflecting growing economic support for connected device-based care outside conventional inpatient settings. Hospital-at-home programs have also demonstrated that high-acuity care can be extended beyond hospital walls using connected monitoring, communication, diagnostics, and device infrastructure.

The market is therefore evolving from a relatively narrow medical IoT connectivity opportunity into an intelligent device-computing layer. Procurement is shifting from asking whether devices can connect to networks toward evaluating what the device can analyze locally, how reliably it operates during network interruptions, how securely it exchanges data, how quickly software can be updated, and whether its output integrates with clinical workflows without overwhelming clinicians.

The 24.7% forecast CAGR reflects the convergence of several high-growth technology cycles rather than a simple increase in device volumes. These include edge AI accelerators, multimodal sensor fusion, software-defined medical devices, real-time computer vision, privacy-preserving analytics, hybrid cloud architectures, 5G-enabled connectivity, clinical-grade cybersecurity, and increasing AI functionality embedded directly inside diagnostic and therapeutic equipment.

 

Introduction

According to the U.S. Edge Computing in Connected Medical Devices Market Report, edge computing is becoming a foundational architecture for the next generation of connected healthcare. The traditional medical device model was based on self-contained equipment generating information that clinicians manually interpreted or periodically transferred into hospital information systems. The connected-device model introduced network communication, but many early architectures still depended heavily on centralized servers or cloud processing.

The emerging edge model distributes intelligence closer to the patient and clinical event. A bedside monitor can process waveforms before transmitting prioritized alerts. A CT or ultrasound system can perform image reconstruction or AI inference immediately after acquisition. A continuous glucose monitor can communicate with an automated insulin-delivery ecosystem. An operating-room platform can process high-resolution video locally for real-time visualization. A home monitoring gateway can filter physiologic data and transmit clinically relevant changes rather than every raw measurement.

This architecture is increasingly necessary because medical-device data volumes are expanding much faster than clinical organizations can manually review them. High-resolution imaging, continuous telemetry, multi-parameter monitoring, video-assisted surgery, connected respiratory therapy, and sensor-rich home care create persistent data streams. Edge computing converts these streams into clinically actionable information closer to the source.

For U.S. health systems, however, adoption is not driven by processing speed alone. Hospital executives increasingly evaluate connected-device infrastructure through total clinical and economic impact. An edge-enabled monitoring platform may justify investment if it reduces alarm burden, prevents deterioration, decreases transfers to higher-acuity beds, or improves nursing productivity. An imaging system with embedded AI may gain preference if it improves examination consistency, reduces reconstruction time, increases equipment throughput, or enables less-specialized staff to complete portions of an examination.

Cybersecurity has become equally important. U.S. medical devices are increasingly connected to hospital networks, remote service environments, cloud platforms, and other devices. Federal requirements introduced under Section 524B of the Federal Food, Drug, and Cosmetic Act have strengthened expectations around cybersecurity for applicable connected medical devices. FDA cybersecurity guidance issued in 2025 further reinforced lifecycle cybersecurity, vulnerability management, secure product development, and documentation expectations.

Edge architectures can reduce some exposure by minimizing unnecessary movement of sensitive data and allowing local execution, but edge computing does not automatically make a medical device secure. Every gateway, processor, firmware layer, software container, wireless connection, API, and remote-management interface expands the architecture that manufacturers must manage throughout the product lifecycle.

Artificial intelligence is another major structural driver. The FDA-authorized AI-enabled medical-device ecosystem has expanded rapidly, particularly in radiology and imaging. Increasingly, these algorithms are moving from remote server execution toward embedded or near-device inference. This shift is strategically important because the highest-value AI applications often operate directly within clinical workflow rather than as a separate retrospective analytics product.

From 2026 through 2035, edge computing is expected to become progressively less visible as a standalone purchasing category because the technology will increasingly be embedded into premium medical devices. The competitive question will shift from whether a manufacturer uses edge computing to how effectively it converts local computing capacity into clinically meaningful differentiation.

 

Key Market Drivers: What’s Fueling the U.S. Edge Computing in Connected Medical Devices Market Boom?

The first major growth driver is the expansion of continuously connected medical devices. Patient monitors, pulse oximeters, wearable ECG systems, continuous glucose monitors, infusion systems, ventilators, imaging equipment, implantable-device programmers, connected respiratory equipment, smart diagnostic systems, and home-monitoring platforms generate increasing quantities of digital information. Processing selected information locally reduces dependence on centralized infrastructure and creates faster pathways from measurement to action.

The second major driver is demand for real-time clinical decision support. Clinical usefulness declines when critical information arrives too late. Edge processing is particularly relevant where latency affects diagnostic quality, intervention timing, or workflow efficiency. In radiology, local accelerated computing can support reconstruction, segmentation, image-quality optimization, and AI-assisted detection. In critical care, edge analytics can prioritize abnormalities from continuous physiologic signals. In surgery, local computing can process video, instrument position, imaging, or navigation data without relying on round trips to distant data centers.

A third driver is the rapid commercialization of AI-enabled medical devices. Major imaging manufacturers are embedding AI into CT, MRI, ultrasound, X-ray, mammography, and other modalities. GE HealthCare, for example, reported reaching 100 FDA-listed AI-enabled device authorizations in the United States by July 2025. As AI becomes an integrated equipment capability rather than a separate software application, demand increases for graphics processors, neural processing units, optimized CPUs, FPGAs, embedded AI modules, thermal management, edge software frameworks, and validated inference environments.

The fourth driver is the growth of remote patient monitoring. Medicare broadly covers qualifying remote physiologic monitoring using internet-connected medical devices, and Medicare RPM payments exceeded USD 500 million during 2024. Connected blood pressure monitors, scales, glucose-monitoring systems, pulse oximeters, cardiac devices, wearable sensors, and other platforms are moving chronic disease management toward continuous or near-continuous data collection.

Edge computing can improve the economics of RPM by filtering redundant information, managing intermittent connectivity, enabling local alerts, reducing cloud transmission requirements, and supporting more intelligent patient-side systems. As remote monitoring programs scale from hundreds to tens of thousands of patients, data-management architecture becomes a material operating issue.

The fifth driver is hospital-at-home and decentralized acute care. U.S. hospital-at-home programs have demonstrated the feasibility of delivering selected inpatient-level services in patient homes. By late 2024, hundreds of hospitals had participated in the federal Acute Hospital Care at Home initiative and more than 31,000 patients had received care through participating programs. Expansion of decentralized care requires reliable monitoring and diagnostic devices capable of operating outside tightly controlled hospital networks.

The sixth driver is hospital labor economics. U.S. health systems continue to experience pressure related to nursing capacity, radiology staffing, specialized technologist availability, and clinician burnout. Connected devices capable of locally prioritizing alarms, improving image acquisition, automating documentation, detecting deterioration, or guiding less-experienced operators can create measurable labor leverage. Procurement committees are increasingly willing to evaluate edge AI when manufacturers can demonstrate a clear relationship between computing capability and workforce productivity.

The seventh driver is resilience. Healthcare organizations have experienced the operational consequences of dependence on centralized digital infrastructure. The 2024 Change Healthcare cyberattack demonstrated how concentrated digital dependencies can affect clinical and financial workflows across the healthcare system. Edge-enabled medical devices that maintain clinically necessary functionality during network outages can provide an additional layer of operational continuity.

The eighth driver is privacy and data governance. Edge processing allows some sensitive information to remain closer to the point of collection. Instead of transferring complete raw video streams, waveforms, or high-resolution sensor data to centralized infrastructure, a device can process information locally and transmit only clinically meaningful outputs. This does not eliminate HIPAA, FDA, cybersecurity, or governance obligations, but it can change the architecture through which protected health information moves.

The ninth driver is the evolution of hospital procurement from capital equipment purchasing toward software-defined lifecycle economics. Edge-enabled medical equipment increasingly receives software updates, AI models, cybersecurity patches, workflow applications, and feature enhancements during its installed life. Manufacturers can therefore generate recurring software and service revenue while hospitals gain more functionality without replacing the underlying equipment.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation is shifting from simply connecting medical devices to making those devices contextually intelligent. The next generation of U.S. connected medical equipment is being designed around local inference, multimodal sensor processing, hybrid cloud connectivity, fleet management, and software-defined functionality.

One of the most important innovation areas is accelerated edge AI. Medical imaging, robotic surgery, endoscopy, ultrasound, pathology, patient monitoring, and advanced diagnostic systems can require substantial parallel computing capability. GPUs, FPGAs, AI accelerators, and neural processing architectures allow manufacturers to execute increasingly sophisticated algorithms within equipment while maintaining predictable latency.

NVIDIA’s Holoscan ecosystem illustrates this movement toward real-time sensor processing for medical devices. The framework is designed to connect high-bandwidth sensor inputs, accelerated computing, AI inference, visualization, and application output within low-latency environments. Such architectures are relevant for endoscopic video, robotic surgery, medical imaging, ultrasound, interventional systems, and sensor-intensive diagnostic equipment.

GE HealthCare and NVIDIA have also expanded development around AI-driven diagnostic imaging. Their work on autonomous X-ray and ultrasound concepts demonstrates where the market is moving: AI is expected to support image acquisition itself, not merely interpret images after acquisition. This creates demand for embedded computing capable of processing sensor information and AI models close to the imaging system.

On-device intelligence is also entering acute-care monitoring. Semiconductor and device manufacturers are evaluating edge AI for anesthesia delivery, neonatal monitoring, critical care, intelligent alarms, and hands-free device interaction. These use cases are commercially attractive because clinicians operate in environments where latency, reliability, distraction, and cognitive workload matter.

Another major innovation area is federated and privacy-preserving analytics. Medical-device manufacturers want to learn from installed fleets without unnecessarily transferring raw patient information into centralized environments. Distributed analytics can allow organizations to evaluate device performance, software utilization, operational metrics, and algorithm behavior while maintaining greater control over sensitive data.

Edge orchestration is becoming equally important. A large hospital can have thousands of connected clinical devices from numerous manufacturers. The commercial value of edge computing therefore depends on the ability to provision software, maintain security certificates, control versions, monitor health, deploy patches, enforce access policies, and manage heterogeneous hardware without creating unsustainable IT workload.

Hybrid edge-cloud architecture is emerging as the preferred model rather than an edge-versus-cloud choice. The edge handles functions requiring speed, availability, privacy, or local interaction. The cloud handles fleet analytics, model development, longitudinal storage, enterprise integration, cross-site coordination, and large-scale computational workloads. Successful manufacturers are designing product architectures where workloads can be allocated between these layers based on clinical and economic requirements.

Interoperability is another competitive frontier. Edge-enabled medical devices must increasingly communicate with electronic health records, enterprise imaging systems, vendor-neutral archives, patient-monitoring platforms, cloud environments, mobile applications, and other medical equipment. Vendors that simplify integration can reduce deployment costs and shorten hospital implementation cycles.

The final innovation priority is lifecycle cybersecurity. Medical-device architecture is increasingly being designed with secure boot, encryption, identity management, hardware roots of trust, signed software updates, vulnerability monitoring, software bills of materials, container controls, and remote patching. Cybersecurity is moving from an IT feature to a product-design requirement that influences FDA submissions, hospital procurement, and long-term service economics.

 

Segmentation Insights

The U.S. Edge Computing in Connected Medical Devices Market is segmented on the basis of component, edge deployment model, connected medical device type, end user, and region.

 

By Component

Edge Hardware and AI Accelerators

Edge hardware represents the foundational compute layer and includes embedded processors, GPUs, neural processing units, FPGAs, industrial PCs, medical-grade compute modules, gateways, storage systems, networking components, and dedicated edge servers. Hardware currently represents a substantial portion of market value because advanced imaging, robotics, monitoring, and high-bandwidth sensor applications require specialized processing capacity.

Growth is increasingly concentrated in compute architectures capable of AI inference with lower power consumption and predictable latency. Medical-device manufacturers also require long component availability, thermal stability, cybersecurity support, and product lifecycle continuity that differ from consumer electronics requirements.

Edge Software, Middleware and Device Management

Software is expected to become the strongest recurring-value component through 2035. This category includes operating environments, inference runtimes, container platforms, device-management software, orchestration, analytics engines, data-processing tools, interoperability middleware, cybersecurity applications, and edge-to-cloud connectivity software.

As connected medical devices become software-defined, manufacturers can update functionality throughout the installed life. Software therefore changes the revenue model from a one-time hardware sale toward recurring licensing, feature activation, fleet management, security subscriptions, and analytics services.

Integration, Engineering and Managed Services

Services include systems integration, clinical workflow design, edge architecture development, cybersecurity implementation, validation, interoperability engineering, deployment, maintenance, AI optimization, and managed device services. Services are especially important in large U.S. health systems because edge architectures often span multiple clinical departments, vendors, facilities, and security domains.

The service opportunity will expand as hospitals demand enterprise standardization rather than isolated device pilots. Suppliers able to provide regulatory-aware engineering and clinical integration will command higher value than generic IT implementation providers.

 

By Edge Deployment Model

On-Device Edge Computing

On-device edge computing processes information directly within the medical equipment or wearable. This approach has the strongest clinical relevance when latency, privacy, reliability, or closed-loop control are critical.

Applications include CGM systems, imaging reconstruction, arrhythmia detection, endoscopic image enhancement, ultrasound AI, infusion safety, ventilator control, robotic navigation, and embedded diagnostic algorithms. On-device edge is expected to gain substantial share because AI accelerators are becoming smaller, more efficient, and increasingly capable of supporting sophisticated models.

Near-Device Gateway Edge

Gateway-edge architectures place compute resources physically close to one or more medical devices. A gateway can aggregate information, translate protocols, apply security controls, filter data, run analytics, and connect legacy or lower-power devices to hospital or cloud environments.

This architecture is particularly attractive in patient rooms, operating rooms, ICUs, imaging departments, ambulatory facilities, and home-monitoring programs where numerous connected devices need coordinated communication.

On-Premises Clinical Edge

Clinical edge infrastructure consists of higher-performance computing installed within hospitals, imaging departments, surgical suites, data centers, or health-system facilities. It supports workloads that are too computationally demanding for individual devices but require lower latency or stronger local data governance than centralized cloud processing.

Large academic centers and integrated delivery networks are leading adopters because they can consolidate multiple AI applications onto shared local infrastructure and reduce the need to install independent servers for each algorithm.

Hybrid Edge-Cloud Architecture

Hybrid edge-cloud is expected to become the dominant long-term architecture. Real-time inference and safety-critical functions are executed locally, while cloud platforms support longitudinal analytics, fleet management, storage, AI training, software distribution, and cross-facility coordination.

This model also gives manufacturers greater commercial flexibility. Device functionality can be sold as an integrated combination of hardware, embedded software, cloud services, and recurring analytics rather than as a standalone piece of equipment.

 

By Connected Medical Device Type

Diagnostic Imaging and Visualization Systems

Diagnostic imaging represents one of the highest-value device categories for edge computing. CT, MRI, ultrasound, X-ray, mammography, PET, interventional imaging, endoscopy, and other visualization systems generate large datasets requiring rapid processing.

AI-enabled reconstruction, image enhancement, segmentation, protocol optimization, abnormality detection, workflow automation, and autonomous acquisition are moving compute closer to imaging equipment. Imaging manufacturers are therefore becoming major buyers of GPUs, AI accelerators, edge software, and hybrid infrastructure.

Patient Monitoring and Critical-Care Devices

Patient monitoring is one of the largest volume opportunities. Bedside monitors, central monitoring systems, pulse oximeters, ECG platforms, wearable monitors, neonatal systems, anesthesia monitors, respiratory systems, and connected ICU devices generate continuous physiological data.

Edge analytics can prioritize clinically meaningful changes, identify deterioration, reduce unnecessary transmission, and support intelligent alarm management. The segment is particularly attractive because monitoring is deployed across large numbers of beds and creates recurring software, integration, and service opportunities.

Connected Diagnostic and Point-of-Care Devices

Connected point-of-care systems include blood analyzers, molecular diagnostics, blood gas platforms, portable ultrasound, cardiac diagnostic devices, digital pathology equipment, connected laboratory instruments, and other decentralized diagnostic platforms.

Edge computing can improve response time, local workflow automation, device quality control, connectivity resilience, and data synchronization. Demand is increasing as diagnostic testing moves closer to patients and outside traditional centralized laboratories.

Connected Therapeutic and Drug-Delivery Devices

This segment includes infusion pumps, automated insulin-delivery ecosystems, respiratory devices, dialysis equipment, neuromodulation systems, implantable-device programmers, and connected therapeutic equipment.

The economic value of edge computing is particularly high where treatment parameters are influenced by continuous sensor information. Continuous glucose monitoring combined with automated insulin delivery is one of the strongest examples of interconnected sensing and therapeutic control.

Surgical, Robotic and Interventional Systems

Surgical robotics, computer-assisted intervention, navigation, endoscopic platforms, digitally connected operating-room systems, and image-guided therapy require extremely low latency and reliable local processing.

High-resolution video, sensor fusion, instrument tracking, 3D visualization, AI assistance, and robotic control create substantial compute requirements. This segment is expected to produce some of the highest per-system edge-computing content through 2035.

 

By End User

Hospitals and Integrated Delivery Networks

Hospitals and IDNs represent the dominant end-user category. They purchase large numbers of connected monitors, imaging systems, surgical platforms, infusion devices, diagnostic systems, and connected therapeutic technologies.

Enterprise health systems increasingly evaluate edge solutions through value-analysis committees, cybersecurity teams, clinical engineering departments, information technology leaders, and medical-device committees. Vendor consolidation and architecture standardization will increasingly influence purchasing decisions.

Ambulatory Surgery Centers and Specialty Clinics

ASCs and specialty practices require compact, lower-complexity connected systems with reliable local processing. Edge-enabled imaging, patient monitoring, endoscopy, cardiology, ophthalmology, orthopedic, and procedure-room systems can allow advanced functionality without the extensive infrastructure available in major hospitals.

Outpatient migration will support this segment because manufacturers must deliver hospital-grade intelligence within smaller footprints and lower-cost operating environments.

Diagnostic Imaging Centers and Laboratories

Imaging centers and laboratories are strong adopters because workflow throughput directly affects revenue generation. Local AI processing can reduce turnaround time, automate quality checks, improve image reconstruction, assist interpretation, and optimize equipment utilization.

Home Healthcare and Remote Monitoring Providers

Home-based care represents one of the fastest-growing end-user segments. Remote patient monitoring, connected respiratory therapy, diabetes management, cardiac monitoring, post-discharge surveillance, and hospital-at-home programs increasingly rely on intelligent device-side processing.

The home environment makes resilience especially important because connectivity is less predictable than within hospitals. Devices capable of local buffering, processing, alerting, and secure synchronization have a competitive advantage.

Emergency Medical Services and Mobile Care

Ambulances, mobile stroke units, emergency response programs, military medicine, and mobile diagnostic environments represent smaller but strategically important markets. Edge computing enables local analysis when bandwidth is constrained and time-to-treatment is critical.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to hospital-system concentration, population growth, health technology ecosystems, AI adoption, academic medical-center density, Medicare population, chronic disease burden, home-monitoring penetration, and availability of advanced clinical infrastructure.

The South is estimated to represent the largest market in 2025 at approximately USD 0.82 billion, followed by the West at USD 0.66 billion, Northeast at USD 0.55 billion, and Midwest at USD 0.45 billion. The West is expected to record the fastest regional CAGR through 2035, while the South should remain the largest absolute revenue opportunity.

South

The South represents the largest U.S. regional opportunity because of its population scale, growing hospital networks, significant Medicare population, high chronic disease burden, expanding metropolitan markets, and strong adoption of remote and decentralized care. The regional market is estimated at approximately USD 0.82 billion in 2025 and could reach approximately USD 7.75 billion by 2035, representing an implied CAGR of roughly 25.2%.

Texas and Florida are the two anchor markets. Texas combines large health systems, academic medical centers, pediatric institutions, cancer centers, cardiovascular programs, imaging networks, and rapidly growing metropolitan areas including Houston, Dallas-Fort Worth, Austin, and San Antonio. Its scale creates demand for enterprise patient monitoring, AI-enabled imaging, connected operating-room technologies, remote monitoring, and distributed edge infrastructure.

Florida is particularly attractive for connected monitoring because of its large older population and high demand for chronic disease management, cardiovascular care, diabetes management, respiratory therapy, hospital-at-home programs, and post-acute monitoring. Edge computing becomes important as healthcare organizations attempt to manage larger patient populations without proportionately increasing specialist staffing.

North Carolina has developed a sophisticated combination of major academic institutions, large health systems, biotechnology companies, data infrastructure, and clinical research capacity. Charlotte, Raleigh-Durham, and surrounding markets provide strong conditions for smart-hospital technologies and AI-enabled diagnostic equipment.

Georgia is supported by Atlanta’s large healthcare ecosystem and rapidly growing population. Tennessee benefits from major hospital operators, healthcare services companies, academic centers, and a concentrated healthcare-management industry. Virginia and Maryland combine advanced provider networks with federal healthcare, cybersecurity, defense, and research institutions, making the corridor strategically important for connected-device security and edge architecture.

South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia represent comparatively smaller technology markets but contain significant chronic disease and access challenges. These states are attractive for scalable remote monitoring, telehealth-connected diagnostics, home-based disease management, and regional hub-and-spoke care models.

Delaware provides a smaller but commercially sophisticated healthcare environment, while the District of Columbia and the broader Washington metropolitan market influence federal policy, cybersecurity requirements, health technology regulation, and government procurement.

The South’s strongest long-term opportunity will come from combining enterprise hospital edge computing with distributed monitoring. Manufacturers that can operate across tertiary hospitals, community facilities, outpatient centers, and patient homes will be positioned more favorably than vendors dependent on a single care setting.

West

The West represents the most innovation-intensive regional market and is projected to record the fastest growth rate through 2035. The market is estimated at approximately USD 0.66 billion in 2025 and could reach around USD 6.70 billion by 2035, implying an approximately 26.1% CAGR.

California dominates the region because it combines a very large healthcare market with Silicon Valley computing expertise, artificial intelligence development, cloud infrastructure, semiconductor innovation, digital health investment, medical-device companies, and world-class academic health systems.

The state is particularly influential in AI-enabled imaging, surgical robotics, computational diagnostics, connected monitoring, digital therapeutics, wearable technologies, and software-defined devices. California health systems also serve as important early-adoption environments for technologies that later scale nationally.

Washington benefits from a strong cloud-computing ecosystem and large technology companies. The presence of hyperscale cloud and enterprise software expertise supports hybrid edge-cloud healthcare architectures and creates a deep workforce for connected-device software development.

Oregon contributes advanced health systems, technology manufacturing, and connected-care adoption. Arizona is a high-growth market because of rapid population expansion, large retirement communities, advanced specialty healthcare, and increasing hospital capacity. These conditions support patient monitoring, cardiovascular connected devices, diabetes technologies, home monitoring, and AI-enabled diagnostics.

Colorado combines strong integrated delivery networks, academic medicine, digital-health entrepreneurship, and an expanding technology workforce. Utah has a growing medical technology ecosystem and favorable conditions for health-system innovation, remote care, and data-driven healthcare delivery.

Nevada is benefiting from rapid population growth and continued investment in hospital and specialty-care infrastructure. New Mexico has greater rural-access requirements, making telehealth, remote diagnostics, and resilient connected-device architectures particularly important.

Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller device markets but strategically relevant for remote and distributed healthcare. Geographic distance and specialist scarcity increase the value of equipment capable of local processing and remote clinical support.

The West is likely to lead commercialization of new edge AI technologies before they become standard across U.S. healthcare. Semiconductor development, AI model innovation, cloud infrastructure, venture funding, medical-device engineering, and advanced provider adoption are unusually concentrated in the region.

Northeast

The Northeast is one of the highest-value regions for advanced connected-device adoption and is estimated at approximately USD 0.55 billion in 2025. The market could reach approximately USD 4.62 billion by 2035, representing an implied CAGR of around 23.7%.

New York represents the largest state-level opportunity because of its hospital density, academic medical centers, large patient population, sophisticated health systems, and concentration of specialty medicine. Large New York provider organizations are important customers for AI-enabled imaging, clinical monitoring, surgical technology, and enterprise interoperability.

Massachusetts has disproportionate strategic importance relative to its population. Boston’s ecosystem of academic hospitals, biotechnology companies, medical-device developers, research institutions, AI companies, and venture investors makes the state an important testing ground for advanced connected medical technologies.

Pennsylvania provides a large market across Philadelphia, Pittsburgh, and regional healthcare systems. The state is attractive for imaging, critical-care monitoring, connected therapeutic devices, and enterprise medical-device integration.

New Jersey benefits from dense healthcare infrastructure, pharmaceutical and life-science industry concentration, proximity to New York and Philadelphia, and a significant medical-technology commercial base.

Connecticut and Rhode Island support advanced academic and community healthcare networks, while Maine, Vermont, and New Hampshire offer smaller but strategically important opportunities for connected care and remote monitoring because of rural populations and specialist-access constraints.

The Northeast is likely to remain one of the most demanding procurement environments. Hospitals in the region typically expect strong clinical evidence, cybersecurity documentation, interoperability, health-economic justification, and demonstrable workflow improvement before broad deployment.

Its relative growth rate is lower than the West and South primarily because the regional healthcare market is more mature and population growth is slower. However, high-acuity medicine, academic research, and premium technology adoption should sustain high revenue per installed device.

Midwest

The Midwest represents an estimated USD 0.45 billion market in 2025 and could reach approximately USD 3.48 billion by 2035, equivalent to an implied CAGR of approximately 22.7%.

Illinois is the largest regional market because of Chicago’s hospital systems, academic medical centers, imaging networks, and large healthcare workforce. Ohio is also strategically important because of its major health systems and strong clinical research infrastructure.

Minnesota holds a unique position because it is one of the most established U.S. medical-technology clusters. The state’s concentration of medical-device expertise supports product development, connected cardiac technologies, monitoring systems, implantable-device ecosystems, and medical software innovation.

Michigan combines major health systems, engineering talent, manufacturing capabilities, and significant chronic disease demand. Wisconsin has advanced provider networks and medical imaging expertise, while Indiana supports large hospital systems and a growing life-sciences sector.

Missouri, Iowa, Kansas, and Nebraska provide stable demand for connected monitoring, diagnostic equipment, hospital automation, and remote specialty care. North Dakota and South Dakota are smaller markets but particularly relevant to technologies designed for rural connectivity and distributed clinical decision support.

The Midwest is expected to show slightly slower growth than the West and South, but its combination of medical-device manufacturing expertise, major integrated delivery networks, and geographically distributed patient populations makes it an important proving ground for scalable clinical edge solutions.

From a national strategy perspective, manufacturers should not treat the four regions as interchangeable. The West rewards early innovation and AI integration; the South provides scale and population growth; the Northeast provides high-acuity reference sites and evidence generation; and the Midwest combines medtech engineering expertise with dependable enterprise health-system demand.

 

Key Market Players

The U.S. Edge Computing in Connected Medical Devices competitive landscape is fragmented across semiconductor suppliers, edge-computing companies, cloud providers, networking vendors, medical-device OEMs, patient-monitoring companies, and clinical software ecosystems.

Some of the key participants relevant to the U.S. market include NVIDIA Corporation, Intel Corporation, Advanced Micro Devices, Qualcomm Technologies, NXP Semiconductors, Amazon Web Services, Microsoft, Google Cloud, Cisco Systems, Dell Technologies, Hewlett Packard Enterprise, IBM, GE HealthCare, Siemens Healthineers, Philips Healthcare, Medtronic, Abbott Laboratories, Dexcom, Baxter International, Masimo, Stryker, Johnson & Johnson MedTech, Boston Scientific, and Real-Time Innovations.

NVIDIA, Intel, AMD, Qualcomm, and NXP compete at the compute and silicon layer. Their strategic importance is increasing because AI processing requirements are becoming integral to medical-device architecture. Success in healthcare depends not simply on chip performance but also on lifecycle support, cybersecurity capabilities, software tooling, power efficiency, deterministic performance, and the ability to support regulated product development.

AWS, Microsoft, Google Cloud, Cisco, Dell, HPE, IBM, and related infrastructure vendors influence hybrid device-to-cloud architecture. Their opportunity lies in connecting edge devices to enterprise environments while providing orchestration, identity management, analytics, security, storage, and fleet services.

GE HealthCare, Siemens Healthineers, and Philips are particularly important in imaging, patient monitoring, clinical workflow, and smart-hospital environments. GE HealthCare’s growing portfolio of AI-enabled device authorizations and collaboration with NVIDIA demonstrate the increasing strategic importance of accelerated computing inside imaging systems.

Medtronic, Abbott, Dexcom, Boston Scientific, Baxter, Masimo, Stryker, and Johnson & Johnson MedTech operate closer to patient monitoring, therapeutic systems, diabetes management, surgery, cardiac care, connected hospital devices, and procedure platforms. Their competitive advantage comes from combining clinical installed bases with connected software and data ecosystems.

Competition will increasingly move away from isolated hardware specifications toward platform characteristics. Hospital buyers will evaluate latency, model performance, cyber resilience, compatibility, integration effort, upgradeability, service burden, clinical evidence, and total ownership cost.

Companies capable of supporting a medical device from embedded compute through edge software, cloud management, cybersecurity, regulatory lifecycle, and clinical workflow integration will capture a disproportionate share of future value.

 

Recent Developments

Recent developments indicate that edge computing is moving from experimental healthcare infrastructure into product-level medical-device design.

In June 2025, the FDA issued updated final cybersecurity guidance for medical devices, reinforcing recommendations around cybersecurity design, documentation, risk management, and regulatory requirements applicable to cyber devices. This development raises the strategic importance of secure device architecture throughout the commercial lifecycle.

In August 2025, the FDA finalized recommendations related to predetermined change control plans for AI-enabled device software functions. The ability to manage planned AI modifications creates an important framework for manufacturers developing software-defined and continuously improving connected devices.

During 2025, GE HealthCare and NVIDIA expanded collaboration around AI-driven autonomous imaging concepts, including X-ray and ultrasound. The work demonstrates how artificial intelligence is moving toward real-time acquisition, workflow automation, and local processing rather than remaining limited to retrospective image analysis.

GE HealthCare also introduced its Genesis enterprise-imaging architecture during 2025, including an edge capability designed to create a secure bi-directional pathway between healthcare environments and cloud infrastructure. This is representative of the broader shift toward hybrid architectures rather than fully centralized cloud models.

By July 2025, GE HealthCare reported 100 AI-enabled medical-device authorizations appearing on the FDA’s U.S. list, indicating the increasing scale at which AI is becoming integrated into regulated medical equipment.

NVIDIA continues to expand Holoscan as a development platform for real-time edge AI and high-bandwidth sensor processing. Use cases span medical imaging, robotics, video processing, and other applications where medical devices require fast AI inference.

NXP and GE HealthCare have also explored on-device edge AI concepts for acute-care equipment, including intelligent anesthesia interaction and neonatal monitoring. These projects demonstrate the potential for edge AI to extend beyond imaging into bedside and therapeutic equipment.

Patient monitoring is also becoming more scalable. Modern centralized monitoring environments can support thousands of beds while extending information through mobile and web workflows. As monitoring estates grow, local analytics and distributed processing become increasingly important to prevent clinical teams from being overwhelmed by raw device data.

Continuous glucose monitoring remains another important demonstration of connected-device intelligence. Modern CGM ecosystems transmit real-time glucose information to compatible smart devices and can interoperate with automated insulin-delivery technologies. The category illustrates the direction of closed-loop and semi-closed-loop connected therapeutic systems.

Remote patient monitoring continues to grow economically. Medicare payments for RPM exceeded USD 500 million in 2024, reinforcing the commercial relevance of connected physiologic devices and creating a larger patient-side infrastructure base for future edge intelligence.

The competitive landscape is therefore entering a new phase in which compute architecture is increasingly part of medical-device differentiation. Vendors that previously competed on sensing quality, mechanical design, imaging performance, or therapeutic delivery are now also competing on software, AI inference, connectivity, cybersecurity, and data-management capability.

 

Conclusion

The U.S. Edge Computing in Connected Medical Devices Market Size & Share is positioned for exceptional expansion from approximately USD 2.48 billion in 2025 to USD 22.55 billion by 2035, representing a 24.7% CAGR during 2026–2035.

The market’s growth is being driven by an architectural shift in medical technology. Connected devices are no longer expected simply to collect information and transmit it somewhere else. Increasingly, they must interpret information, prioritize signals, execute AI models, maintain function during network disruption, communicate securely with surrounding systems, and support software-driven improvement throughout their installed life.

Diagnostic imaging and visualization will remain among the largest value pools because of the computational intensity of reconstruction and AI. Patient monitoring will provide a larger volume opportunity because thousands of connected monitoring points can exist within a single health system. Surgical and robotic platforms will command substantial computing content per system because of their low-latency requirements.

Home healthcare represents a particularly attractive growth frontier. Remote patient monitoring, hospital-at-home programs, diabetes management, cardiovascular monitoring, respiratory therapy, and post-acute surveillance are moving connected devices into less-controlled environments where intelligent local processing becomes increasingly valuable.

From a procurement perspective, hospitals will become less willing to fund technology solely because it contains AI or edge functionality. Buyers will demand evidence that the architecture improves measurable outcomes such as examination throughput, clinician productivity, alarm burden, diagnostic turnaround, device uptime, cybersecurity resilience, length of stay, outpatient capacity, or avoidable utilization.

Manufacturers must therefore integrate computing decisions into product strategy much earlier. Processor architecture, software updateability, cybersecurity, data governance, cloud integration, AI model management, and component lifecycle availability will increasingly affect regulatory strategy and commercial competitiveness.

Regional opportunity will remain diverse. The South is expected to retain the largest absolute market because of population scale, expanding health systems, chronic disease burden, and decentralized-care demand. The West should record the fastest growth because of its concentration of AI, semiconductor, cloud, digital-health, and medical-technology innovation. The Northeast will remain crucial for high-acuity clinical validation and premium adoption, while the Midwest provides a strong combination of medtech expertise, integrated delivery networks, and distributed-care demand.

For companies evaluating the U.S. market, the central commercial question is not whether connected medical devices will use more computing. That trajectory is already established. The important questions are where computation will occur, which workloads must remain local, how AI will be validated and updated, which clinical workflows justify premium edge architectures, and how manufacturers can convert embedded intelligence into recurring economic value.

The companies positioned to define the market through 2035 will be those that treat edge computing not as an IT add-on but as part of the medical device itself. Clinical reliability, low-latency intelligence, cybersecurity, interoperability, lifecycle software management, and measurable healthcare economics will collectively determine which platforms become embedded within the next generation of U.S. connected medical care.

 

TABLE OF CONTENT

1. U.S. Edge Computing in Connected Medical Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up and Top-Down Market Sizing Approach
1.3.6. Analytical Frameworks & Forecasting Models
1.3.7. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Boundary and Inclusion/Exclusion Criteria
1.5.1. Embedded Edge Computing within Medical Devices
1.5.2. Near-Device Medical Edge Gateways
1.5.3. On-Premises Clinical Edge Infrastructure Supporting Connected Devices
1.5.4. Edge Software, AI Inference and Device Orchestration
1.5.5. Exclusion of General Healthcare IT Edge Infrastructure Unrelated to Medical Devices
1.6. Market Ecosystem Overview
1.7. Stakeholder Analysis
1.7.1. Connected Medical Device Manufacturers
1.7.2. Semiconductor, GPU, NPU and Embedded Computing Suppliers
1.7.3. Edge Software and Middleware Providers
1.7.4. Cloud and Hybrid Edge Infrastructure Providers
1.7.5. Hospitals and Integrated Delivery Networks
1.7.6. Ambulatory and Specialty Care Providers
1.7.7. Home Healthcare and Remote Monitoring Providers
1.7.8. Systems Integrators and Medical Device Connectivity Providers
1.7.9. FDA, CMS, Payers and Cybersecurity Decision-Makers

What this section provides: This section establishes the market boundary, research methodology, inclusion criteria, assumptions, value-chain structure, and stakeholder ecosystem required to understand how the U.S. edge computing in connected medical devices market is measured and validated.

2. U.S. Edge Computing in Connected Medical Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size & CAGR Snapshot
2.8. Highest-Growth Technology Opportunities
2.9. Highest-Growth Connected Medical Device Categories
2.10. Critical Hospital Adoption Priorities
2.11. Regional Opportunity Snapshot
2.12. Strategic Investment Hotspots

What this section provides: This section gives executives a concise view of market size, historical development, forecast direction, high-growth technologies, device categories, regional demand, competitive intensity, and priority commercial opportunities.

3. U.S. Edge Computing in Connected Medical Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Installed Base of Connected Medical Devices
3.1.2. Expansion of AI-Enabled Medical Devices
3.1.3. Growing Need for Low-Latency Clinical Decision Support
3.1.4. Increasing Medical Device Data Volumes
3.1.5. Expansion of Remote Patient Monitoring
3.1.6. Growth of Hospital-at-Home and Distributed Care Models
3.1.7. Increasing Demand for Local Processing and Network Resilience
3.1.8. Growing Hospital Focus on Cybersecurity and Data Sovereignty
3.1.9. Increasing Use of AI-Enabled Diagnostic Imaging
3.1.10. Clinical Workforce Shortages and Workflow Automation Requirements
3.2. Restraints and Their Impact Analysis
3.2.1. High Edge Infrastructure and Integration Costs
3.2.2. Fragmented Medical Device Connectivity Standards
3.2.3. Legacy Medical Equipment Integration Challenges
3.2.4. Cybersecurity and Attack-Surface Expansion
3.2.5. Limited In-House Edge AI and Clinical Engineering Expertise
3.2.6. Long Medical Device Replacement Cycles
3.2.7. Regulatory Complexity for Continuously Updated AI-Enabled Devices
3.3. Opportunities and Their Impact Analysis
3.3.1. Embedded Edge AI in Diagnostic Imaging
3.3.2. Intelligent Patient Monitoring and Predictive Analytics
3.3.3. Surgical Robotics and Real-Time Computer Vision
3.3.4. Edge Computing for Remote Patient Monitoring
3.3.5. Hospital-at-Home Medical Device Ecosystems
3.3.6. Privacy-Preserving and Federated Clinical AI
3.3.7. Software-Defined Medical Devices
3.3.8. Hybrid Edge-Cloud Clinical Architectures
3.3.9. 5G-Enabled Connected Medical Devices
3.3.10. Edge Device Fleet Management and Lifecycle Services
3.4. Challenges and Their Impact Analysis
3.4.1. Interoperability Across Multi-Vendor Device Environments
3.4.2. AI Model Validation and Drift Management
3.4.3. Deterministic Performance and Clinical Reliability Requirements
3.4.4. Hardware Lifecycle and Semiconductor Availability
3.4.5. Secure Over-the-Air Medical Device Updates
3.4.6. Demonstrating Hospital ROI and Clinical Economic Value
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Edge AI Innovation Cycle Analysis
3.7. Medical Device Software Lifecycle Analysis
3.8. Clinical Workflow Economics Analysis
3.9. Hospital Capital Procurement Behavior Analysis
3.10. Edge-versus-Cloud Workload Economics Analysis

What this section provides: This section examines the technological, clinical, financial, regulatory, cybersecurity, and operational factors influencing adoption and helps clients evaluate both the commercial upside and execution risks of edge-enabled medical devices.

4. U.S. Edge Computing in Connected Medical Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Healthcare Buyers
4.2.3. Bargaining Power of Semiconductor and Compute Suppliers
4.2.4. Threat of Substitute Architectures
4.2.5. Competitive Rivalry
4.3. Edge Computing Pricing Trend Analysis, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Semiconductor and Processor Layer
4.4.2. Embedded Compute Module Layer
4.4.3. Edge Operating Environment and Middleware Layer
4.4.4. Connected Medical Device OEM Layer
4.4.5. Integration and Clinical Deployment Layer
4.4.6. Hospital and Home-Care Delivery Layer
4.5. Impact of Digitalization and Software-Defined Medical Devices
4.6. Edge AI Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Software as a Medical Device Considerations
4.7.2. AI-Enabled Medical Device Framework
4.7.3. Cyber Device Requirements
4.7.4. Predetermined Change Control Plans
4.8. Medical Device Cybersecurity Regulatory Landscape
4.9. CMS Reimbursement and Connected-Care Coverage Landscape
4.10. HIPAA, Patient Privacy and Data Governance Considerations
4.11. Interoperability Standards and Medical Device Connectivity
4.12. Semiconductor Supply Chain and Component Availability Analysis
4.13. Import/Export Restrictions & Tariff Impact
4.14. Government Digital Health and Connected-Care Initiatives
4.15. Impact of Escalating Geopolitical Tensions
4.16. Hospital Value Analysis Committee Decision Framework
4.17. Medical Device Cybersecurity Procurement Framework

What this section provides: This section gives clients a comprehensive view of the external market environment, including regulation, cybersecurity, reimbursement, supply chain, AI adoption, interoperability, pricing, data governance, and healthcare procurement dynamics.

5. U.S. Edge Computing in Connected Medical Devices Market – By Component

5.1. Overview
5.1.1. Segment Share Analysis, By Component, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
5.2. Edge Hardware
5.2.1. CPUs and Embedded Processors
5.2.2. GPUs
5.2.3. AI Accelerators and NPUs
5.2.4. FPGAs
5.2.5. Medical-Grade Edge Servers
5.2.6. Embedded Computing Modules
5.2.7. Medical Device Gateways
5.2.8. Edge Storage and Networking Components
5.3. Edge Software & Middleware
5.3.1. Edge Operating Environments
5.3.2. AI Inference Runtime Software
5.3.3. Device Orchestration Platforms
5.3.4. Medical Device Connectivity Middleware
5.3.5. Data Processing and Analytics Software
5.3.6. Edge-to-Cloud Integration Software
5.4. Edge Cybersecurity Solutions
5.4.1. Device Identity and Access Management
5.4.2. Secure Boot and Hardware Root of Trust
5.4.3. Encryption and Data Protection
5.4.4. Vulnerability and Patch Management
5.4.5. Edge Network Security
5.4.6. Medical Device Threat Detection
5.5. Integration, Engineering & Managed Services
5.5.1. Systems Integration
5.5.2. Edge Architecture Consulting
5.5.3. AI Model Optimization
5.5.4. Clinical Workflow Integration
5.5.5. Cybersecurity Engineering
5.5.6. Managed Edge Infrastructure Services

What this section provides: This section identifies the hardware, software, cybersecurity, integration, and services layers generating market revenue and determines where value creation is expected to shift as connected medical devices become increasingly software-defined and AI-enabled.

6. U.S. Edge Computing in Connected Medical Devices Market – By Edge Deployment Model

6.1. Overview
6.1.1. Segment Share Analysis, By Edge Deployment Model, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Edge Deployment Model, 2021–2035 (US$ Billion)
6.2. On-Device Edge Computing
6.2.1. Embedded AI Processing
6.2.2. Embedded Signal Processing
6.2.3. Device-Level Clinical Decision Support
6.2.4. Closed-Loop and Real-Time Therapeutic Control
6.3. Near-Device Gateway Edge
6.3.1. Bedside Medical Gateways
6.3.2. Operating Room Edge Gateways
6.3.3. Imaging Department Gateways
6.3.4. Home Healthcare Edge Gateways
6.3.5. Multi-Device Data Aggregation Platforms
6.4. On-Premises Clinical Edge
6.4.1. Hospital Edge Servers
6.4.2. Departmental Edge Computing
6.4.3. Local AI Inference Clusters
6.4.4. Enterprise Medical Device Edge Infrastructure
6.5. Hybrid Edge-Cloud Architecture
6.5.1. Local Inference with Cloud Analytics
6.5.2. Edge-Based Clinical Processing with Cloud Storage
6.5.3. Hybrid AI Model Management
6.5.4. Multi-Site Edge-to-Cloud Medical Device Management

What this section provides: This section evaluates where medical-device computation occurs and helps clients understand the relative commercial attractiveness of embedded, gateway, hospital edge, and hybrid edge-cloud architectures through 2035.

7. U.S. Edge Computing in Connected Medical Devices Market – By Connected Medical Device Type

7.1. Overview
7.1.1. Segment Share Analysis, By Connected Medical Device Type, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By Connected Medical Device Type, 2021–2035 (US$ Billion)
7.2. Diagnostic Imaging & Visualization Systems
7.2.1. Computed Tomography Systems
7.2.2. Magnetic Resonance Imaging Systems
7.2.3. Ultrasound Systems
7.2.4. X-Ray and Digital Radiography Systems
7.2.5. Mammography Systems
7.2.6. Nuclear Imaging Systems
7.2.7. Endoscopy and Surgical Visualization Systems
7.2.8. Interventional Imaging Systems
7.3. Patient Monitoring & Critical-Care Devices
7.3.1. Multi-Parameter Patient Monitors
7.3.2. ECG and Cardiac Monitoring Systems
7.3.3. Pulse Oximetry Systems
7.3.4. Anesthesia Monitoring Systems
7.3.5. Neonatal Monitoring Systems
7.3.6. Ventilators and Respiratory Monitoring Devices
7.3.7. Wearable Medical Monitoring Devices
7.4. Connected Diagnostic & Point-of-Care Devices
7.4.1. Point-of-Care Blood Analyzers
7.4.2. Molecular Diagnostic Systems
7.4.3. Blood Gas Analyzers
7.4.4. Portable Diagnostic Systems
7.4.5. Connected Laboratory Instruments
7.4.6. Digital Pathology and Computational Diagnostic Systems
7.5. Connected Therapeutic & Drug-Delivery Devices
7.5.1. Infusion Pumps
7.5.2. Continuous Glucose Monitoring Systems
7.5.3. Automated Insulin Delivery Systems
7.5.4. Connected Respiratory Therapy Devices
7.5.5. Dialysis Equipment
7.5.6. Neuromodulation and Connected Therapeutic Devices
7.5.7. Implantable Device Programming and Monitoring Systems
7.6. Surgical, Robotic & Interventional Systems
7.6.1. Surgical Robotic Systems
7.6.2. Image-Guided Surgery Systems
7.6.3. Navigation Systems
7.6.4. Smart Operating Room Platforms
7.6.5. Computer-Assisted Interventional Systems

What this section provides: This section determines which connected medical device categories create the largest and fastest-growing demand for edge processing, AI acceleration, low-latency analytics, cybersecurity, and hybrid device-to-cloud architectures.

8. U.S. Edge Computing in Connected Medical Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
8.2. Hospitals & Integrated Delivery Networks
8.2.1. Academic Medical Centers
8.2.2. Large Integrated Health Systems
8.2.3. Community Hospitals
8.2.4. Specialty Hospitals
8.3. Ambulatory Surgery Centers & Specialty Clinics
8.3.1. Ambulatory Surgery Centers
8.3.2. Cardiology Clinics
8.3.3. Oncology Centers
8.3.4. Orthopedic and Surgical Specialty Centers
8.3.5. Other Specialty Practices
8.4. Diagnostic Imaging Centers & Laboratories
8.4.1. Independent Diagnostic Imaging Centers
8.4.2. Hospital-Affiliated Imaging Centers
8.4.3. Clinical Laboratories
8.4.4. Point-of-Care Diagnostic Networks
8.5. Home Healthcare & Remote Monitoring Providers
8.5.1. Remote Patient Monitoring Providers
8.5.2. Hospital-at-Home Programs
8.5.3. Home Respiratory Care Providers
8.5.4. Chronic Disease Management Platforms
8.5.5. Post-Acute Monitoring Providers
8.6. Emergency Medical Services & Mobile Care
8.6.1. Ambulance Services
8.6.2. Mobile Stroke and Critical-Care Units
8.6.3. Mobile Diagnostic Services
8.6.4. Military and Federal Mobile Healthcare Systems

What this section provides: This section identifies the healthcare environments expected to drive purchasing and deployment of edge-enabled medical devices and evaluates how infrastructure requirements differ between hospitals, outpatient facilities, diagnostic centers, patient homes, and mobile-care environments.

9. U.S. Edge Computing in Connected Medical Devices Market: Commercial Adoption, Procurement & Deployment Analysis

9.1. Overview
9.2. Medical Device OEM Embedded Edge Procurement
9.3. Direct Hospital and Health System Edge Infrastructure Procurement
9.4. Integrated Delivery Network Enterprise Edge Contracts
9.5. Cloud and Edge Platform Subscription Models
9.6. Systems Integrator-Led Deployments
9.7. Medical Device Connectivity Vendor Partnerships
9.8. Managed Edge Infrastructure Models
9.9. Semiconductor and Embedded Module Supply Agreements
9.10. Software Licensing and AI Runtime Commercial Models
9.11. Capital Expenditure versus Operating Expenditure Analysis
9.12. Hospital Proof-of-Concept to Enterprise Deployment Cycle
9.13. Procurement Decision-Maker Analysis
9.13.1. Chief Information Officers
9.13.2. Chief Medical Information Officers
9.13.3. Clinical Engineering Leadership
9.13.4. Biomedical Engineering Teams
9.13.5. Cybersecurity Leadership
9.13.6. Value Analysis Committees
9.13.7. Clinical Department Leadership
9.14. Vendor Selection and Contracting Criteria
9.15. Total Cost of Ownership Analysis
9.16. Hospital ROI and Clinical Economic Assessment

What this section provides: This section explains how edge-computing technologies are purchased, embedded, contracted, implemented, and scaled within the U.S. connected medical device ecosystem, without adding an additional formal market segmentation beyond the report’s five core segmentation dimensions including geography.

10. U.S. Edge Computing in Connected Medical Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Connected Medical Device Installed Base Analysis
10.1.4. Regional Edge AI Adoption Analysis
10.1.5. Regional Hospital and IDN Infrastructure Analysis
10.1.6. Regional Remote Patient Monitoring Adoption
10.1.7. Regional AI-Enabled Imaging Adoption
10.1.8. Regional Procurement and Cybersecurity Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Edge Computing and Connected Medical Device Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Component, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Edge Deployment Model, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Connected Medical Device Type, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Commercial Adoption & Procurement Analysis
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Component, 2021–2035
10.2.9.3. California Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.9.4. California Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035
10.2.9.6. California Commercial Adoption & Procurement Analysis
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Component, 2021–2035
10.2.10.3. Washington Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.10.4. Washington Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035
10.2.10.6. Washington Commercial Adoption & Procurement Analysis
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Component, 2021–2035
10.2.11.3. Arizona Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.11.4. Arizona Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035
10.2.11.6. Arizona Commercial Adoption & Procurement Analysis
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Component, 2021–2035
10.2.12.3. Colorado Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.12.4. Colorado Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035
10.2.12.6. Colorado Commercial Adoption & Procurement Analysis
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Component, 2021–2035
10.2.13.3. Oregon Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.13.4. Oregon Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035
10.2.13.6. Oregon Commercial Adoption & Procurement Analysis
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Component, 2021–2035
10.2.14.3. Utah Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.14.4. Utah Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035
10.2.14.6. Utah Commercial Adoption & Procurement Analysis
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Component, 2021–2035
10.2.15.3. Nevada Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.15.4. Nevada Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035
10.2.15.6. Nevada Commercial Adoption & Procurement Analysis
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Component, 2021–2035
10.2.16.3. New Mexico Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.16.4. New Mexico Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035
10.2.16.6. New Mexico Commercial Adoption & Procurement Analysis
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Component, 2021–2035
10.2.17.3. Idaho Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.17.4. Idaho Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035
10.2.17.6. Idaho Commercial Adoption & Procurement Analysis
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Component, 2021–2035
10.2.18.3. Montana Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.18.4. Montana Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035
10.2.18.6. Montana Commercial Adoption & Procurement Analysis
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Component, 2021–2035
10.2.19.3. Wyoming Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.19.4. Wyoming Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035
10.2.19.6. Wyoming Commercial Adoption & Procurement Analysis
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Component, 2021–2035
10.2.20.3. Alaska Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.20.4. Alaska Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035
10.2.20.6. Alaska Commercial Adoption & Procurement Analysis
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Component, 2021–2035
10.2.21.3. Hawaii Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.2.21.4. Hawaii Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035
10.2.21.6. Hawaii Commercial Adoption & Procurement Analysis
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Edge Computing and Connected Medical Device Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035
10.3.4. Northeast Region Market Size and Forecast, By Component, 2021–2035
10.3.5. Northeast Region Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.6. Northeast Region Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035
10.3.8. Northeast Region Commercial Adoption & Procurement Analysis
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Component, 2021–2035
10.3.9.3. New York Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.9.4. New York Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035
10.3.9.6. New York Commercial Adoption & Procurement Analysis
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Component, 2021–2035
10.3.10.3. Massachusetts Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.10.4. Massachusetts Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035
10.3.10.6. Massachusetts Commercial Adoption & Procurement Analysis
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Component, 2021–2035
10.3.11.3. New Jersey Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.11.4. New Jersey Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035
10.3.11.6. New Jersey Commercial Adoption & Procurement Analysis
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Component, 2021–2035
10.3.12.3. Pennsylvania Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.12.4. Pennsylvania Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035
10.3.12.6. Pennsylvania Commercial Adoption & Procurement Analysis
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Component, 2021–2035
10.3.13.3. Connecticut Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.13.4. Connecticut Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035
10.3.13.6. Connecticut Commercial Adoption & Procurement Analysis
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Component, 2021–2035
10.3.14.3. Maine Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.14.4. Maine Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035
10.3.14.6. Maine Commercial Adoption & Procurement Analysis
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Component, 2021–2035
10.3.15.3. Vermont Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.15.4. Vermont Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035
10.3.15.6. Vermont Commercial Adoption & Procurement Analysis
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Component, 2021–2035
10.3.16.3. New Hampshire Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.16.4. New Hampshire Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035
10.3.16.6. New Hampshire Commercial Adoption & Procurement Analysis
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Component, 2021–2035
10.3.17.3. Rhode Island Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.17.4. Rhode Island Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035
10.3.17.6. Rhode Island Commercial Adoption & Procurement Analysis
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Component, 2021–2035
10.3.18.3. Delaware Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.3.18.4. Delaware Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035
10.3.18.6. Delaware Commercial Adoption & Procurement Analysis
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Edge Computing and Connected Medical Device Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035
10.4.4. South Region Market Size and Forecast, By Component, 2021–2035
10.4.5. South Region Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.6. South Region Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035
10.4.8. South Region Commercial Adoption & Procurement Analysis
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Component, 2021–2035
10.4.9.3. Texas Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.9.4. Texas Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035
10.4.9.6. Texas Commercial Adoption & Procurement Analysis
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Component, 2021–2035
10.4.10.3. Florida Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.10.4. Florida Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035
10.4.10.6. Florida Commercial Adoption & Procurement Analysis
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Component, 2021–2035
10.4.11.3. Georgia Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.11.4. Georgia Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035
10.4.11.6. Georgia Commercial Adoption & Procurement Analysis
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Component, 2021–2035
10.4.12.3. North Carolina Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.12.4. North Carolina Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035
10.4.12.6. North Carolina Commercial Adoption & Procurement Analysis
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Component, 2021–2035
10.4.13.3. Tennessee Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.13.4. Tennessee Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035
10.4.13.6. Tennessee Commercial Adoption & Procurement Analysis
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Component, 2021–2035
10.4.14.3. South Carolina Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.14.4. South Carolina Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035
10.4.14.6. South Carolina Commercial Adoption & Procurement Analysis
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Component, 2021–2035
10.4.15.3. Alabama Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.15.4. Alabama Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035
10.4.15.6. Alabama Commercial Adoption & Procurement Analysis
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Component, 2021–2035
10.4.16.3. Mississippi Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.16.4. Mississippi Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035
10.4.16.6. Mississippi Commercial Adoption & Procurement Analysis
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Component, 2021–2035
10.4.17.3. Louisiana Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.17.4. Louisiana Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035
10.4.17.6. Louisiana Commercial Adoption & Procurement Analysis
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Component, 2021–2035
10.4.18.3. Arkansas Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.18.4. Arkansas Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035
10.4.18.6. Arkansas Commercial Adoption & Procurement Analysis
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Component, 2021–2035
10.4.19.3. Kentucky Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.19.4. Kentucky Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035
10.4.19.6. Kentucky Commercial Adoption & Procurement Analysis
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Component, 2021–2035
10.4.20.3. Oklahoma Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.20.4. Oklahoma Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035
10.4.20.6. Oklahoma Commercial Adoption & Procurement Analysis
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Component, 2021–2035
10.4.21.3. Virginia Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.21.4. Virginia Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035
10.4.21.6. Virginia Commercial Adoption & Procurement Analysis
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Component, 2021–2035
10.4.22.3. Maryland Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.22.4. Maryland Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035
10.4.22.6. Maryland Commercial Adoption & Procurement Analysis
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Component, 2021–2035
10.4.23.3. West Virginia Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.4.23.4. West Virginia Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035
10.4.23.6. West Virginia Commercial Adoption & Procurement Analysis
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Edge Computing and Connected Medical Device Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035
10.5.4. Midwest Region Market Size and Forecast, By Component, 2021–2035
10.5.5. Midwest Region Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.6. Midwest Region Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035
10.5.8. Midwest Region Commercial Adoption & Procurement Analysis
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Component, 2021–2035
10.5.9.3. Illinois Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.9.4. Illinois Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035
10.5.9.6. Illinois Commercial Adoption & Procurement Analysis
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Component, 2021–2035
10.5.10.3. Ohio Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.10.4. Ohio Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035
10.5.10.6. Ohio Commercial Adoption & Procurement Analysis
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Component, 2021–2035
10.5.11.3. Michigan Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.11.4. Michigan Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035
10.5.11.6. Michigan Commercial Adoption & Procurement Analysis
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Component, 2021–2035
10.5.12.3. Minnesota Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.12.4. Minnesota Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035
10.5.12.6. Minnesota Commercial Adoption & Procurement Analysis
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Component, 2021–2035
10.5.13.3. Indiana Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.13.4. Indiana Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035
10.5.13.6. Indiana Commercial Adoption & Procurement Analysis
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Component, 2021–2035
10.5.14.3. Wisconsin Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.14.4. Wisconsin Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035
10.5.14.6. Wisconsin Commercial Adoption & Procurement Analysis
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Component, 2021–2035
10.5.15.3. Missouri Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.15.4. Missouri Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035
10.5.15.6. Missouri Commercial Adoption & Procurement Analysis
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Component, 2021–2035
10.5.16.3. Iowa Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.16.4. Iowa Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035
10.5.16.6. Iowa Commercial Adoption & Procurement Analysis
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Component, 2021–2035
10.5.17.3. Kansas Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.17.4. Kansas Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035
10.5.17.6. Kansas Commercial Adoption & Procurement Analysis
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Component, 2021–2035
10.5.18.3. Nebraska Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.18.4. Nebraska Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035
10.5.18.6. Nebraska Commercial Adoption & Procurement Analysis
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Component, 2021–2035
10.5.19.3. North Dakota Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.19.4. North Dakota Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035
10.5.19.6. North Dakota Commercial Adoption & Procurement Analysis
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Component, 2021–2035
10.5.20.3. South Dakota Market Size and Forecast, By Edge Deployment Model, 2021–2035
10.5.20.4. South Dakota Market Size and Forecast, By Connected Medical Device Type, 2021–2035
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035
10.5.20.6. South Dakota Commercial Adoption & Procurement Analysis

What this section provides: This section delivers detailed regional and state-level intelligence across all 50 U.S. states, enabling clients to identify connected-device adoption hotspots, edge-AI innovation clusters, major health-system opportunities, remote-care demand centers, state-level commercial priorities, and regional procurement differences.

11. U.S. Edge Computing in Connected Medical Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Semiconductor and Edge Compute Provider Share
11.1.2. Edge Platform and Infrastructure Provider Positioning
11.1.3. Connected Medical Device OEM Positioning
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking
11.3.1. Edge AI Processing Capability
11.3.2. Medical Device Installed Base
11.3.3. Edge-to-Cloud Integration Capability
11.3.4. Cybersecurity Capability
11.3.5. Regulatory Readiness
11.3.6. Clinical Workflow Integration
11.3.7. U.S. Healthcare Commercial Reach
11.4. Company Profiles
11.4.1. NVIDIA Corporation
11.4.2. Intel Corporation
11.4.3. Advanced Micro Devices, Inc.
11.4.4. Qualcomm Technologies, Inc.
11.4.5. NXP Semiconductors N.V.
11.4.6. Amazon Web Services, Inc.
11.4.7. Microsoft Corporation
11.4.8. Google Cloud
11.4.9. Cisco Systems, Inc.
11.4.10. Dell Technologies Inc.
11.4.11. Hewlett Packard Enterprise
11.4.12. IBM Corporation
11.4.13. GE HealthCare Technologies Inc.
11.4.14. Siemens Healthineers AG
11.4.15. Koninklijke Philips N.V.
11.4.16. Medtronic plc
11.4.17. Abbott Laboratories
11.4.18. Dexcom, Inc.
11.4.19. Baxter International Inc.
11.4.20. Masimo Corporation
11.4.21. Stryker Corporation
11.4.22. Johnson & Johnson MedTech
11.4.23. Boston Scientific Corporation
11.4.24. Real-Time Innovations, Inc.
11.5. Company Profile Coverage Framework
11.5.1. Company Overview
11.5.2. Edge Computing and Connected Medical Device Portfolio
11.5.3. U.S. Healthcare Market Strategy
11.5.4. AI and Embedded Computing Capabilities
11.5.5. Edge-to-Cloud Ecosystem
11.5.6. Medical Device Partnerships
11.5.7. Financial Positioning
11.5.8. Regulatory and Cybersecurity Positioning
11.5.9. Product Launches and Innovation Pipeline
11.5.10. Partnerships, Acquisitions and Recent Developments

What this section provides: This section gives clients competitor benchmarking, market positioning, ecosystem visibility, AI and edge-compute capability assessment, connected-device portfolio analysis, strategic partnerships, and intelligence on leading U.S. market participants.

12. U.S. Edge Computing in Connected Medical Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Generative AI at the Medical Edge
12.2.2. Multimodal Edge AI
12.2.3. Medical-Grade AI Accelerators and NPUs
12.2.4. Federated Learning
12.2.5. Privacy-Preserving AI
12.2.6. Autonomous Diagnostic Imaging
12.2.7. Intelligent Patient Monitoring
12.2.8. Surgical Robotics and Computer Vision
12.2.9. 5G and Private Wireless Healthcare Networks
12.2.10. Software-Defined Medical Devices
12.2.11. Digital Twins and Predictive Device Maintenance
12.2.12. Edge-Based Closed-Loop Therapeutic Systems
12.3. Edge-versus-Cloud Architecture Outlook
12.4. Evolution of Medical Device AI Regulation
12.5. Future Medical Device Cybersecurity Requirements
12.6. Emerging Business Models
12.7. Software and Recurring Revenue Expansion
12.8. Business Opportunities for Startups and Existing Players
12.9. Semiconductor and Embedded Computing Opportunity Outlook
12.10. Medical Device OEM Partnership Opportunities
12.11. Hospital Enterprise Edge Opportunity
12.12. Investment Prioritization Matrix
12.13. Technology Adoption Roadmap, 2026–2035

What this section provides: This section prepares clients for changes in edge AI, computing architectures, medical-device software, regulation, cybersecurity, recurring revenue models, investment priorities, and adoption scenarios through 2035.

13. U.S. Edge Computing in Connected Medical Devices Market: Strategic Recommendations

13.1. Recommendations for Connected Medical Device Manufacturers
13.1.1. Embedded Edge AI Product Strategy
13.1.2. Processor and Compute Architecture Strategy
13.1.3. Cybersecurity-by-Design Strategy
13.1.4. Edge-to-Cloud Integration Strategy
13.1.5. AI Model Lifecycle Management
13.2. Recommendations for Semiconductor and Edge Computing Vendors
13.2.1. Medical-Grade Product Lifecycle Support
13.2.2. Regulatory-Aware Development Tools
13.2.3. OEM Partnership Strategy
13.3. Recommendations for Hospitals and Integrated Delivery Networks
13.3.1. Enterprise Edge Architecture Standardization
13.3.2. Medical Device Cybersecurity Governance
13.3.3. Clinical ROI Measurement
13.3.4. Vendor Consolidation Strategy
13.4. Recommendations for Cloud and Infrastructure Providers
13.4.1. Hybrid Edge-Cloud Healthcare Strategy
13.4.2. Medical Device Fleet Management
13.4.3. Healthcare AI Infrastructure Partnerships
13.5. Recommendations for Investors and Private Equity Firms
13.5.1. High-Growth Technology Screening
13.5.2. Platform versus Point-Solution Assessment
13.5.3. Recurring Revenue Opportunity Evaluation
13.6. Recommendations for Systems Integrators and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. U.S. Health System Enterprise Sales Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Partnership, Licensing and M&A Opportunity Framework
13.12. Clinical Evidence and Health Economic Value Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product design, edge architecture, commercialization, hospital sales, partnerships, investments, portfolio expansion, cybersecurity positioning, and competitive differentiation.

14. U.S. Edge Computing in Connected Medical Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. State-Level Estimation Limitation
14.6. Technology Classification Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer
14.9. Regulatory and Reimbursement Information Disclaimer

What this section provides: This section clarifies the report’s scope, market-estimation boundaries, state-level modeling limitations, forecasting assumptions, technology classifications, legal conditions, and third-party data-use considerations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Edge Computing in Connected Medical Devices Market: Market Definition and Scope
TABLE 3: U.S. Edge Computing in Connected Medical Devices Market: Research Methodology Framework
TABLE 4: U.S. Edge Computing in Connected Medical Devices Market: Key Assumptions
TABLE 5: U.S. Edge Computing in Connected Medical Devices Market: Market Boundary and Inclusion/Exclusion Criteria
TABLE 6: U.S. Edge Computing in Connected Medical Devices Market: Market Ecosystem Overview
TABLE 7: U.S. Edge Computing in Connected Medical Devices Market: Stakeholder Analysis
TABLE 8: U.S. Edge Computing in Connected Medical Devices Market: Executive Summary Snapshot, 2025
TABLE 9: U.S. Edge Computing in Connected Medical Devices Market: Analyst Viewpoint Summary
TABLE 10: U.S. Edge Computing in Connected Medical Devices Market: Market Attractiveness Index
TABLE 11: U.S. Edge Computing in Connected Medical Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 12: U.S. Edge Computing in Connected Medical Devices Market: Base Year Market Positioning, 2025
TABLE 13: U.S. Edge Computing in Connected Medical Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 14: U.S. Edge Computing in Connected Medical Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 15: U.S. Edge Computing in Connected Medical Devices Market: Drivers; Impact Analysis
TABLE 16: U.S. Edge Computing in Connected Medical Devices Market: Restraints; Impact Analysis
TABLE 17: U.S. Edge Computing in Connected Medical Devices Market: Opportunities; Impact Analysis
TABLE 18: U.S. Edge Computing in Connected Medical Devices Market: Challenges; Impact Analysis
TABLE 19: U.S. Edge Computing in Connected Medical Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Edge Computing in Connected Medical Devices Market: Edge AI Innovation Cycle Analysis
TABLE 21: U.S. Edge Computing in Connected Medical Devices Market: Medical Device Software Lifecycle Analysis
TABLE 22: U.S. Edge Computing in Connected Medical Devices Market: Clinical Workflow Economics Matrix
TABLE 23: U.S. Edge Computing in Connected Medical Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 24: U.S. Edge Computing in Connected Medical Devices Market: Edge-versus-Cloud Workload Economics
TABLE 25: U.S. Edge Computing in Connected Medical Devices Market: Connected Device Adoption Barrier Matrix
TABLE 26: U.S. Edge Computing in Connected Medical Devices Market: PESTEL Analysis
TABLE 27: U.S. Edge Computing in Connected Medical Devices Market: Porter’s Five Forces Analysis
TABLE 28: U.S. Edge Computing in Connected Medical Devices Market: Edge Computing Pricing Trend Analysis, 2025–2035
TABLE 29: U.S. Edge Computing in Connected Medical Devices Market: Value Chain Analysis
TABLE 30: U.S. Edge Computing in Connected Medical Devices Market: Supply Chain Analysis
TABLE 31: U.S. Edge Computing in Connected Medical Devices Market: Software-Defined Medical Device Impact
TABLE 32: U.S. Edge Computing in Connected Medical Devices Market: Edge AI Application & Innovation Landscape
TABLE 33: U.S. Edge Computing in Connected Medical Devices Market: FDA Regulatory Framework Analysis
TABLE 34: U.S. Edge Computing in Connected Medical Devices Market: Medical Device Cybersecurity Regulatory Landscape
TABLE 35: U.S. Edge Computing in Connected Medical Devices Market: CMS Reimbursement and Connected-Care Coverage Landscape
TABLE 36: U.S. Edge Computing in Connected Medical Devices Market: HIPAA and Data Governance Considerations
TABLE 37: U.S. Edge Computing in Connected Medical Devices Market: Semiconductor Supply Chain and Tariff Impact
TABLE 38: U.S. Edge Computing in Connected Medical Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 39: U.S. Edge Computing in Connected Medical Devices Market: Component Snapshot, 2025
TABLE 40: Segment Dashboard; Definition and Scope, by Component
TABLE 41: U.S. Edge Computing in Connected Medical Devices Market, by Component, 2021–2035 (US$ Billion)
TABLE 42: U.S. Edge Computing in Connected Medical Devices Market: Segment Share Analysis, by Component, 2025 & 2035 (%)
TABLE 43: Edge Hardware Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: Edge Software & Middleware Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: Edge Cybersecurity Solutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: Integration, Engineering & Managed Services Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Edge Computing in Connected Medical Devices Market: Edge Deployment Model Snapshot, 2025
TABLE 48: Segment Dashboard; Definition and Scope, by Edge Deployment Model
TABLE 49: U.S. Edge Computing in Connected Medical Devices Market, by Edge Deployment Model, 2021–2035 (US$ Billion)
TABLE 50: Segment Share Analysis, by Edge Deployment Model, 2025 & 2035 (%)
TABLE 51: On-Device Edge Computing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Near-Device Gateway Edge Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: On-Premises Clinical Edge Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Hybrid Edge-Cloud Architecture Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Edge Computing in Connected Medical Devices Market: Connected Medical Device Type Snapshot, 2025
TABLE 56: Segment Dashboard; Definition and Scope, by Connected Medical Device Type
TABLE 57: U.S. Edge Computing in Connected Medical Devices Market, by Connected Medical Device Type, 2021–2035 (US$ Billion)
TABLE 58: Segment Share Analysis, by Connected Medical Device Type, 2025 & 2035 (%)
TABLE 59: Diagnostic Imaging & Visualization Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Patient Monitoring & Critical-Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Connected Diagnostic & Point-of-Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Connected Therapeutic & Drug-Delivery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Surgical, Robotic & Interventional Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Edge Computing in Connected Medical Devices Market: End User Snapshot, 2025
TABLE 65: Segment Dashboard; Definition and Scope, by End User
TABLE 66: U.S. Edge Computing in Connected Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 67: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 68: Hospitals & Integrated Delivery Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: Ambulatory Surgery Centers & Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Diagnostic Imaging Centers & Laboratories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: Home Healthcare, Remote Monitoring & Mobile Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Edge Computing in Connected Medical Devices Market: Commercial Adoption Snapshot, 2025
TABLE 73: Medical Device OEM Embedded Edge Procurement Analysis
TABLE 74: Hospital and IDN Edge Infrastructure Procurement Analysis
TABLE 75: Cloud and Edge Platform Subscription Model Analysis
TABLE 76: Systems Integrator and Connectivity Vendor Deployment Models
TABLE 77: Semiconductor and Embedded Module Supply Agreement Analysis
TABLE 78: Capital Expenditure versus Operating Expenditure Analysis
TABLE 79: Hospital Proof-of-Concept to Enterprise Deployment Cycle
TABLE 80: Total Cost of Ownership and Clinical ROI Analysis
TABLE 81: U.S. Edge Computing in Connected Medical Devices Market: Regional Snapshot, 2025
TABLE 82: Segment Dashboard; Definition and Scope, by Geography
TABLE 83: U.S. Edge Computing in Connected Medical Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 84: U.S. Edge Computing in Connected Medical Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 85: West Region U.S. Edge Computing in Connected Medical Devices Market: Regional Overview and Trends
TABLE 86: West Region: Key Edge Computing and Connected Medical Device Ecosystem
TABLE 87: West Region Market, by State, 2021–2035 (US$ Billion)
TABLE 88: West Region Market, by Component, 2021–2035 (US$ Billion)
TABLE 89: West Region Market, by Edge Deployment Model, 2021–2035 (US$ Billion)
TABLE 90: West Region Market, by Connected Medical Device Type, 2021–2035 (US$ Billion)
TABLE 91: West Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 92: California Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 93: Washington Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 94: Arizona Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 95: Colorado Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 96: Oregon Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 97: Utah Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 98: Nevada Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 99: New Mexico Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 100: Idaho Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 101: Montana Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 102: Wyoming Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 103: Alaska Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 104: Hawaii Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 105: Northeast Region U.S. Edge Computing in Connected Medical Devices Market: Regional Overview and Trends
TABLE 106: Northeast Region: Key Edge Computing and Connected Medical Device Ecosystem
TABLE 107: Northeast Region Market, by State, 2021–2035 (US$ Billion)
TABLE 108: Northeast Region Market, by Component, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region Market, by Edge Deployment Model, 2021–2035 (US$ Billion)
TABLE 110: Northeast Region Market, by Connected Medical Device Type, 2021–2035 (US$ Billion)
TABLE 111: Northeast Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: New York Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 113: Massachusetts Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 114: New Jersey Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 115: Pennsylvania Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 116: Connecticut Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 117: Maine Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 118: Vermont Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 119: New Hampshire Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 120: Rhode Island Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 121: Delaware Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 122: South Region U.S. Edge Computing in Connected Medical Devices Market: Regional Overview and Trends
TABLE 123: South Region: Key Edge Computing and Connected Medical Device Ecosystem
TABLE 124: South Region Market, by State, 2021–2035 (US$ Billion)
TABLE 125: South Region Market, by Component, 2021–2035 (US$ Billion)
TABLE 126: South Region Market, by Edge Deployment Model, 2021–2035 (US$ Billion)
TABLE 127: South Region Market, by Connected Medical Device Type, 2021–2035 (US$ Billion)
TABLE 128: South Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 129: Texas Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 130: Florida Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 131: Georgia Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 132: North Carolina Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 133: Tennessee Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 134: South Carolina Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 135: Alabama Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 136: Mississippi Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 137: Louisiana Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 138: Arkansas Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 139: Kentucky Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 140: Oklahoma Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 141: Virginia Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 142: Maryland Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 143: West Virginia Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 144: Midwest Region U.S. Edge Computing in Connected Medical Devices Market: Regional Overview and Trends
TABLE 145: Midwest Region: Key Edge Computing and Connected Medical Device Ecosystem
TABLE 146: Midwest Region Market, by State, 2021–2035 (US$ Billion)
TABLE 147: Midwest Region Market, by Component, 2021–2035 (US$ Billion)
TABLE 148: Midwest Region Market, by Edge Deployment Model, 2021–2035 (US$ Billion)
TABLE 149: Midwest Region Market, by Connected Medical Device Type, 2021–2035 (US$ Billion)
TABLE 150: Midwest Region Market, by End User, 2021–2035 (US$ Billion)
TABLE 151: Illinois Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 152: Ohio Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 153: Michigan Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 154: Minnesota Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 155: Indiana Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 156: Wisconsin Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 157: Missouri Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 158: Iowa Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 159: Kansas Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 160: Nebraska Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 161: North Dakota Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 162: South Dakota Edge Computing in Connected Medical Devices Market, 2021–2035 (US$ Billion)
TABLE 163: U.S. Edge Computing in Connected Medical Devices Market: Competitive Landscape Snapshot, 2025
TABLE 164: U.S. Edge Computing in Connected Medical Devices Market: Key Company Market Share Analysis, 2025
TABLE 165: U.S. Edge Computing in Connected Medical Devices Market: Company Positioning Matrix
TABLE 166: U.S. Edge Computing in Connected Medical Devices Market: Competitive Capability Benchmarking
TABLE 167: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 168: NVIDIA Corporation: Company Profile
TABLE 169: Intel Corporation: Company Profile
TABLE 170: Advanced Micro Devices, Inc.: Company Profile
TABLE 171: Qualcomm Technologies, Inc.: Company Profile
TABLE 172: NXP Semiconductors N.V.: Company Profile
TABLE 173: Amazon Web Services, Inc.: Company Profile
TABLE 174: Microsoft Corporation: Company Profile
TABLE 175: Google Cloud: Company Profile
TABLE 176: Cisco Systems, Inc.: Company Profile
TABLE 177: Dell Technologies Inc.: Company Profile
TABLE 178: Hewlett Packard Enterprise: Company Profile
TABLE 179: IBM Corporation: Company Profile
TABLE 180: GE HealthCare Technologies Inc.: Company Profile
TABLE 181: Siemens Healthineers AG: Company Profile
TABLE 182: Koninklijke Philips N.V.: Company Profile
TABLE 183: Medtronic plc: Company Profile
TABLE 184: Abbott Laboratories: Company Profile
TABLE 185: Dexcom, Inc.: Company Profile
TABLE 186: Baxter International Inc.: Company Profile
TABLE 187: Masimo Corporation: Company Profile
TABLE 188: Stryker Corporation: Company Profile
TABLE 189: Johnson & Johnson MedTech: Company Profile
TABLE 190: Boston Scientific Corporation: Company Profile
TABLE 191: Real-Time Innovations, Inc.: Company Profile
TABLE 192: U.S. Edge Computing in Connected Medical Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 193: U.S. Edge Computing in Connected Medical Devices Market: Disruptive Technologies Impact Matrix
TABLE 194: Edge-versus-Cloud Architecture Outlook, 2026–2035
TABLE 195: Medical Device AI and Cybersecurity Regulatory Outlook
TABLE 196: Emerging Business Models and Recurring Revenue Opportunities
TABLE 197: Business Opportunities for Startups and Existing Players
TABLE 198: U.S. Edge Computing in Connected Medical Devices Market: Investment Prioritization Matrix
TABLE 199: Strategic Recommendations for Connected Medical Device Manufacturers
TABLE 200: Strategic Recommendations for Semiconductor and Edge Computing Vendors
TABLE 201: Strategic Recommendations for Hospitals and Integrated Delivery Networks
TABLE 202: Strategic Recommendations for Cloud and Infrastructure Providers
TABLE 203: Strategic Recommendations for Investors and Private Equity Firms
TABLE 204: U.S. Edge Computing in Connected Medical Devices Market: Go-to-Market Strategy Considerations
TABLE 205: Product Positioning, Partnership and Portfolio Expansion Guidance
TABLE 206: U.S. Edge Computing in Connected Medical Devices Market: Scope Limitation
TABLE 207: U.S. Edge Computing in Connected Medical Devices Market: Market Definition Limitation
TABLE 208: U.S. Edge Computing in Connected Medical Devices Market: Data Use Limitation
TABLE 209: U.S. Edge Computing in Connected Medical Devices Market: Forecasting Limitation
TABLE 210: U.S. Edge Computing in Connected Medical Devices Market: State-Level Estimation Limitation
TABLE 211: U.S. Edge Computing in Connected Medical Devices Market: Technology Classification Limitation
TABLE 212: U.S. Edge Computing in Connected Medical Devices Market: Legal Disclaimer
TABLE 213: U.S. Edge Computing in Connected Medical Devices Market: Third-Party Data Disclaimer
TABLE 214: U.S. Edge Computing in Connected Medical Devices Market: Regulatory and Reimbursement Disclaimer

List of Figures

FIGURE 1: U.S. Edge Computing in Connected Medical Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Edge Computing in Connected Medical Devices Market Ecosystem
FIGURE 4: U.S. Edge Computing in Connected Medical Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 5: U.S. Edge Computing in Connected Medical Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 6: U.S. Edge Computing in Connected Medical Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: U.S. Edge Computing in Connected Medical Devices Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Edge AI Innovation Cycle
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: PESTEL Analysis
FIGURE 14: Porter’s Five Forces Analysis
FIGURE 15: Value Chain Analysis
FIGURE 16: Supply Chain Analysis
FIGURE 17: Edge-to-Cloud Connected Medical Device Architecture
FIGURE 18: FDA and Medical Device Cybersecurity Framework
FIGURE 19: Medical Device Interoperability and Data Flow Framework
FIGURE 20: Hospital Value Analysis and Cybersecurity Procurement Framework
FIGURE 21: Component Segment Market Share Analysis, 2025 & 2035
FIGURE 22: Component Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 23: Edge Hardware Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 24: Edge Software & Middleware Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 25: Edge Cybersecurity Solutions Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 26: Integration, Engineering & Managed Services Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 27: Edge Deployment Model Market Share Analysis, 2025 & 2035
FIGURE 28: Edge Deployment Model Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 29: On-Device Edge Computing Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 30: Near-Device Gateway Edge Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 31: On-Premises Clinical Edge Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 32: Hybrid Edge-Cloud Architecture Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 33: Connected Medical Device Type Market Share Analysis, 2025 & 2035
FIGURE 34: Connected Medical Device Type Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 35: Diagnostic Imaging & Visualization Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 36: Patient Monitoring & Critical-Care Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: Connected Diagnostic & Point-of-Care Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 38: Connected Therapeutic & Drug-Delivery Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 39: Surgical, Robotic & Interventional Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 41: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 42: Hospitals & Integrated Delivery Networks Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 43: Ambulatory Surgery Centers & Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 44: Diagnostic Imaging Centers & Laboratories Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 45: Home Healthcare, Remote Monitoring & Mobile Care Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 46: Medical Device Edge Procurement Ecosystem
FIGURE 47: Hospital Proof-of-Concept to Enterprise Edge Deployment Cycle
FIGURE 48: Capital Expenditure versus Operating Expenditure Framework
FIGURE 49: Connected Medical Device Procurement Decision-Maker Map
FIGURE 50: Total Cost of Ownership and Clinical ROI Framework
FIGURE 51: Regional Market Share Analysis, 2025 & 2035
FIGURE 52: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: West Region Market Share and Leading Players, 2025
FIGURE 54: West Region Market Share Analysis by State, 2025
FIGURE 55: West Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 56: California Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 57: Washington Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 58: Arizona Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 59: Colorado Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 60: Oregon Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 61: Utah Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 62: Nevada Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 63: New Mexico Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 64: Idaho Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 65: Montana Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 66: Wyoming Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 67: Alaska Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 68: Hawaii Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 69: Northeast Region Market Share and Leading Players, 2025
FIGURE 70: Northeast Region Market Share Analysis by State, 2025
FIGURE 71: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 72: New York Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 73: Massachusetts Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 74: New Jersey Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 75: Pennsylvania Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 76: Connecticut Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 77: Maine Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 78: Vermont Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 79: New Hampshire Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 80: Rhode Island Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 81: Delaware Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 82: South Region Market Share and Leading Players, 2025
FIGURE 83: South Region Market Share Analysis by State, 2025
FIGURE 84: South Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 85: Texas Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 86: Florida Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 87: Georgia Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 88: North Carolina Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 89: Tennessee Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 90: South Carolina Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 91: Alabama Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 92: Mississippi Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 93: Louisiana Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 94: Arkansas Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 95: Kentucky Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 96: Oklahoma Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 97: Virginia Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 98: Maryland Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 99: West Virginia Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 100: Midwest Region Market Share and Leading Players, 2025
FIGURE 101: Midwest Region Market Share Analysis by State, 2025
FIGURE 102: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 103: Illinois Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 104: Ohio Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 105: Michigan Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 106: Minnesota Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 107: Indiana Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 108: Wisconsin Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 109: Missouri Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 110: Iowa Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 111: Kansas Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 112: Nebraska Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 113: North Dakota Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 114: South Dakota Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 115: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 116: Company Positioning Matrix
FIGURE 117: Edge Computing Capability Benchmarking of Key Players
FIGURE 118: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 119: U.S. Connected Medical Device Edge Computing Ecosystem Map
FIGURE 120: Future Market Scenario Analysis, 2026–2035
FIGURE 121: Disruptive Technologies Impact Matrix
FIGURE 122: Edge-versus-Cloud Architecture Evolution Roadmap
FIGURE 123: Medical Device Edge AI Adoption Roadmap
FIGURE 124: Emerging Business Trends Matrix
FIGURE 125: Investment Prioritization Matrix
FIGURE 126: Strategic Growth Roadmap for Connected Medical Device Manufacturers
FIGURE 127: U.S. Health System Go-to-Market Strategy Framework
FIGURE 128: Product Positioning, Partnership and Portfolio Expansion Framework
FIGURE 129: Edge Computing Commercialization and Investment Priority Framework
FIGURE 130: Report Scope, Market Boundary and Disclaimer Framework